Lataa...
Measure for measure: minimal residual disease in CLL
In this issue of Blood, Kwok and colleagues have provided a wealth of retrospective clinical data that greatly expands our appreciation for the prognostic importance of flow-cytometric residual disease measurement across a spectrum of clinical presentations in chronic lymphocytic leukemia (CLL).(1)
Tallennettuna:
| Julkaisussa: | Blood |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5159707/ https://ncbi.nlm.nih.gov/pubmed/27979863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-11-745323 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|